International Medical Corps dreamt of the perfect solution to help injured disaster survivors — a portable, rapidly deployable, fully functional hospital. Rebecca Milner explains how FedEx helped to make the impossible possible.
Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts
Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are. His team at BU recently issued a study highlighting these gaps, and emphasizing the need for companies to better document the impact of their programs.
Cargill partners with school districts across America to expand menu options and boost nutrition
by Marino Eccher
Start with scrambled eggs. Add a smorgasbord of potential fixings – diced peppers, onions, ham, crumbled sausage, shredded cheese – and a handful of sauces ranging from barbecue to soy. Spend 10 minutes mixing it all together and you might impress Charlie, an eighth grader at Indian Hills Junior High School in West Des Moines, Iowa.
Charlie has been selected to be the student culinary judge as his peers compete in their own version of the popular Food Network show “Chopped.”
Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
By Dr. Ann Aerts, Head of the Novartis Foundation
Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.
Better Hearts Better Cities is an initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension
Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
Non-communicable diseases (NCDs), including cardiovascular disease, are a growing health crisis with 75% of NCD deaths occurring in low- and middle-income countries; this is compounded by rapid urbanization.
The innovative approach is being tested on three continents: in Mongolia, Senegal, and Brazil.
Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.
May 12, 2017 /3BL Media/ -- We are pleased to announce that Novartis and the Ministry of National Health Services, Regulation and Coordination of the Islamic Republic of Pakistan have signed a Memorandum of Understanding to implement Novartis Access in Pakistan. Novartis Access medicines will be made available to the poorest population through hospitals under the Prime Minister’s National Health Insurance Program.
With increasing public health concerns associated with Legionnaires’ disease and waterborne healthcare associated infections (WHAIs), it’s not surprising that more than 200 healthcare professionals and building owners and operators attended Nalco Water’s April 20 conference in Baltimore on strategies to reduce the risk of waterborne pathogens.
27 April 2017 is a significant day for road safety in Tunisia: seat belts became mandatory for all drivers and front seat passengers. Next year, the law will be extended to back seat passengers. Previously, seat belts were only required on rural highways and most people did not wear them in urban areas.
FOSTER CITY, Calif., May 1, 2017 /3BL Media/ - Gilead Sciences, Inc. today announced that it issued its Year in Review 2016 report, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.
The report focuses on four key areas: giving and access, people, products and environment as well as a financial overview. Highlights include: